Clinical Trials Solutionssp. z o.o.
Other data processing, hosting and related activities
Overview
Clinical Trials Solutions is a provider of the SMARTrials® platform, an integrated Clinical Trials Management Platform (CTMP) that supports research teams in managing clinical trials effectively. The platform consolidates key processes for planning, monitoring, evaluating, and improving both business efficiency and the quality of clinical research. It offers tools designed to enhance recruitment strategies and patient retention for clinical research centers and organizations managing studies.
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2018-03-01. Active
78 1050 1722 1000 0090 8033 9550
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
7 public aid cases recorded, with a total value of $146,030.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 27, 2022 | Other crisis aid | $16,601$16,601 | Tarnowska Agencja Rozwoju Regionalnego S.A. | |
| Jun 27, 2022 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $3,971$3,971 | Tarnowska Agencja Rozwoju Regionalnego S.A. | |
| Sep 21, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $115.4K$115,391 | Tarnowska Agencja Rozwoju Regionalnego S.A. |
Tenders
3 tenders recorded as contractor: 2 national ($336,574) and 1 EU ($148,035).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Jul 21, 2026 | „Zakup systemów teleinformatycznych, jakościowych i innych wspierających zarządzanie Badaniami klinicznymi w tym: System do zarządzania badaniami klinicznymi oraz System do realizacji studium wykonalności (ang. feasibility)” w ramach projektu „Centrum Wsparcia Badań Klinicznych dla Mazowsza Zachodniego”. | $148.0K$148,035 | Mazowieckie Centrum Leczenia Chorób Płuc I Gruźlicy | |
| Apr 17, 2026 | Zakup i wdrożenie zintegrowanego systemu informatycznego do zarządzania badaniami klinicznymi w ramach projektu "Centrum Wsparcia Badań Klinicznych dla Mazowsza Zachodniego" | $182.6K$182,604 | Centrum Zdrowia Mazowsza Zachodniego sp. z o.o. | |
| Apr 18, 2023 | ZP/2/2023 - Usługa zaprojektowania, wdrożenia, świadczenia serwisu gwarancyjnego i nadzoru oraz wsparcia systemu informatycznego dla Onkologicznego Centrum Wsparcia Badań Klinicznych Instytutu „CZMP” | $154.0K$153,971 | Instytut Centrum Zdrowia Matki Polki |
Authorized Representatives
Manner of representation
In the case of a one-person management board, the President of the Management Board acts independently. In the case of a multi-member management board, the company shall be represented by the President of the Management Board acting independently, or by two members of the management board acting jointly.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 231 | $3,119.94 | 33.3333% | |
Marek Konieczny (56) | 231 | $3,119.94 | 33.3333% |
Stanisław Pisarski (66) | 231 | $3,119.94 | 33.3333% |
Beneficial owners
| Person | Rights | |
|---|---|---|
Andrzej Bogusz (59)  | Posiada 100% udziałów w arbet investment group sp. z o.o., która posiada 100% udziałów w arbet park sp. z o.o., która posiada 231 udziałów w spółce o łącznej wartości nominalnej 11.550 pln | |
Marek Konieczny (56) | Shareholder of a limited liability company, 11550.0 PLN | |
Stanisław Pisarski (66) | Shareholder of a limited liability company, 11550.0 PLN |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Turbo TradeS.A. | $253,102.31 | turbotrade.pl | ||
| Chory.Plsp. z o.o. | $241,401.58 | chory.pl | ||
| Multisourcesp. z o.o. | $177,399.15 | multi-source.pl | ||
| ImpleP.S.A. | $31,810.70 | imple.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-07-10 | Share capital change (24,250.00 PLN → 34,650.00 PLN) | |
| 2025-05-23 | Address change (Pl. Dworcowy 4, 33-100, Tarnów → Złota 75a/7, 00-819, Warszawa) | |
| 2025-05-23 | Share capital change (23,500.00 PLN → 24,250.00 PLN) | |
| 2025-05-23 | PKD change (Removed: 46.51.Z, 62.01.Z, 62.02.Z, 62.03.Z, 63.11.Z, 63.12.Z; Added: 46.50.Z, 60.39.Z, 62.10.B, 62.20.A, 62.20.B, 62.90.Z, 63.10.A, 63.10.D, 72.10.Z) | |
| 2019-04-16 | Share capital change (20,000.00 PLN → 23,500.00 PLN) |
FAQ
Last updated: 2026-07-20